T2 Biosystems, Inc. Announces Exclusive Distribution Agreement in Taiwan
November 19, 2021 at 09:00 am EST
Share
T2 Biosystems, Inc. announced the execution of a territory exclusive distribution agreement in Taiwan. Under the terms of the agreement, T2 Biosystems will sell T2Dx Instruments, along with T2Bacteria, T2Candida and T2Resistance Panels through this distributor. The execution of this distribution agreement includes an initial purchase of three T2Dx Instruments and marks T2 Biosystems? third entry in the Asia-Pacific market during the last 30 days. According to the Asia Pacific Sepsis Alliance, the estimated national sepsis incidences in this region ranges from 120 up to 1,600 per 100,000. The incidence of sepsis is 287 per 100,000 people in Taiwan and a recent analysis estimated the national health expenditure of 33.5 billion NT dollars for sepsis hospitalizations was higher than those for cancer and diabetes, estimated at 23.0 billion and 1.5 billion NT dollars, respectively. T2 Biosystems and its new distribution partner are collaborating with the health authorities in Taiwan to gain regulatory approval and offer patients the higher quality sepsis care available.
T2 Biosystems, Inc. is an in vitro diagnostics company focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The Company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. It also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.